Salt Lake City, UT (July 24, 2024) 4Life’s Research and Development Department commissioned a double-blind, randomized, placebo-controlled, cross-over clinical study to investigate how rapidly 4Life Transfer Factor
® Tri-Factor
® formula activates the immune system in healthy subjects. This “gold standard” study was recently published in
Current Issues in Molecular Biology, a peer-reviewed research publication.
The study was independently conducted by NIS Labs, a premiere clinical research laboratory that specializes in investigating the immune benefits of natural products.
Chief Scientific Officer Dr. David Vollmer: “Studies like these are the lifeblood of research-based companies like 4Life, which has decades worth of transfer factor science. These results suggest that 4Life Transfer Factor activates within two hours.
1*”
For more than twenty-five years, 4Life has been a world leading innovator in the immune system nutraceutical sciences. The company makes significant ongoing investments in scientific research and development, publication, quality manufacturing, patents, and overall customer satisfaction.
For more information about this and other research, visit the company’s
Studies and Publications.
4Life, The Immune System Company
®, and the first to bring transfer factor research to market, has offices in dozens of countries to serve the company’s worldwide customers.
For more information:
Calvin Jolley
Vice President Corporate Communications
4Life Research
[email protected]
*This statement has not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
1. Yu, L.; Iloba, I.; Cruickshank, D.; Jensen, G.S. Feasibility Trial Exploring Immune-Related Biomarkers Pertaining to Rapid Immune Surveillance and Cytokine Changes after Consuming a Nutraceutical Supplement Containing Colostrum- and Egg-Based Low-Molecular-Weight Peptides. Curr. Issues Mol. Biol. 2024, 46, 6710-6724.
